指南与共识妇科

局部晚期宫颈癌中的碎片化诊疗与符合指南的治疗

Fragmented Care and Guideline-Concordant Treatment in Locally Advanced Cervical Cancer.
指南 / 共识 · Obstet Gynecol · 2025-02-27

这项单机构回顾性研究纳入2003年1月至2023年9月的286例局部晚期宫颈癌(IB3-IVA期)患者,75.5%接受碎片化诊疗;非碎片化诊疗组接受符合指南治疗的比例显著高于碎片化组(71.4% vs 50.9%,P=.003),碎片化诊疗与符合指南治疗几率降低独立相关。

要点

  • 75.5%的局部晚期宫颈癌患者接受碎片化诊疗。
  • 非碎片化组符合指南治疗率71.4%,碎片化组50.9%(P=.003)。
  • 碎片化诊疗与符合指南治疗几率降低独立相关(OR 0.45,95%CI 0.23-0.90)。

核心结论

  • 超过75%的患者接受碎片化诊疗,碎片化诊疗与符合指南治疗率显著降低相关。

研究设计与样本

  • 单机构回顾性研究,纳入2003年1月至2023年9月局部晚期宫颈癌(IB3-IVA期)患者286例,按是否在本机构接受全部诊疗分为碎片化组和非碎片化组。

主要发现

  • 非碎片化组接受符合指南治疗的比例为71.4%,碎片化组为50.9%(P=.003)。
  • 非碎片化组按时完成治疗的比例为81.4%,碎片化组为60.6%(P=.001)。
  • 单因素分析显示碎片化诊疗(OR 0.42,95%CI 0.23-0.74)和医疗补助保险(OR 0.40,95%CI 0.20-0.78)与符合指南治疗几率降低显著相关。
  • 控制保险类型和社会脆弱性指数后,碎片化诊疗(OR 0.45,95%CI 0.23-0.90)和医疗补助保险(OR 0.42,95%CI 0.19-0.89)与符合指南治疗几率降低独立相关。
  • 控制人口学协变量后,碎片化诊疗(OR 0.39,95%CI 0.18-0.84)和医疗补助保险(OR 0.35,95%CI 0.16-0.78)与符合指南治疗几率降低相关。

关键数值与推荐

  • 符合指南治疗定义为复合终点:56天内完成治疗、完成近距离放疗、接受同步化疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize and estimate rates of fragmented care, to investigate its association with the receipt of guideline-concordant treatment, and to evaluate treatment components at risk with fragmented care. METHODS: This is a single-institution retrospective study of patients with locally advanced cervical cancer (stage IB3-IVA) from January 2003 to September 2023. We stratified patients into fragmented and nonfragmented care groups based on receipt of all care at our institution or if they received any component of care outside of our institution. The primary outcome, receipt of guideline-concordant treatment , was defined as a composite of 1) completion of treatment within 56 days, 2) completion of brachytherapy, and 3) receipt of concurrent chemotherapy. Demographic and treatment data were collected, including the Social Vulnerability Index (SVI), a census tract-based measure of disadvantage. Univariate and multivariate analyses were performed. RESULTS: Two hundred eighty-six patients were identified; 75.5% received fragmented care. Those receiving nonfragmented care were significantly more likely to receive guideline-concordant treatment than those receiving fragmented care (71.4% vs 50.9%, P =.003). This was driven primarily by rates of timely completion (81.4% vs 60.6%, P =.001). Univariate analysis indicated that fragmented care (odds ratio [OR] 0.42, 95% CI, 0.23-0.74) and Medicaid insurance (OR 0.40, 95% CI, 0.20-0.78) were significantly associated with lower odds of guideline-concordant treatment. Multivariate analyses controlling for a priori confounders of insurance type and SVI showed that fragmented care (OR 0.45, 95% CI, 0.23-0.90) and Medicaid insurance (OR 0.42, 95% CI, 0.19-0.89) were independently associated with lower odds of guideline-concordant treatment. Multivariate analysis controlling for demographic covariates found even lower odds of receiving guideline-concordant treatment in those who received fragmented care (OR 0.39, 95% CI, 0.18-0.84) and who had Medicaid insurance (OR 0.35, 95% CI, 0.16-0.78). CONCLUSION: More than 75% of patients received fragmented care, which had a significant clinical effect and was associated with significantly lower rates of guideline-concordant treatment.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Mvemba A, Liang J, Swanson M, et al. Fragmented Care and Guideline-Concordant Treatment in Locally Advanced Cervical Cancer. Obstet Gynecol. 2025. PMID: 40014865. doi:10.1097/AOG.0000000000005869

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。